Item 5.07 Submission of Matters to a Vote of Security Holders.



  On June 2, 2021, Adamas Pharmaceuticals, Inc. (the "Company") held its Annual
Meeting of Stockholders (the "Annual Meeting"). Set forth below is a brief
description of each matter considered and voted upon at the Annual Meeting,
together with the final tally of the number of votes cast for, against or
withheld, as well as the number of abstentions and broker non-votes as to each
such matter, as applicable, including a separate tabulation with respect to each
of the three directors. A more complete description of each matter is set forth
in the Company's Definitive Proxy Statement on Schedule 14A filed with the U.S.
Securities and Exchange Commission on April 19, 2021.

Proposal No. 1 - Election of Directors
The Company's stockholders elected the three Class I director nominees to the
Company's Board of Directors to hold office until the 2024 Annual Meeting of
Stockholders or until their successors are elected. The vote was as follows:
Class I Director Nominees                                         Votes For                   Votes Withheld                  Broker Non-Votes
Martha J. Demski                                                  24,341,973                     1,540,649                        8,258,250
William W. Ericson                                                24,144,704                     1,737,918                        8,258,250
Spyridon Papapetropoulos, M.D., Ph.D.                             24,497,736                     1,384,886                        8,258,250


Proposal No. 2 - Approval, on an advisory basis, of the compensation of the
Company's named executive officers
The Company's stockholders approved, on an advisory basis, the compensation of
the Company's named executive officers. The vote was as follows:

Votes For Votes Against Abstentions Broker Non-Votes


 22,467,423         3,372,660            42,539             8,258,250


Proposal No. 3 - Ratification of the selection of independent registered
accounting firm
The Company's stockholders ratified the selection of PricewaterhouseCoopers LLC
as the independent registered public accounting firm of the Company for its
fiscal year ending December 31, 2021. The vote was as follows:
 Votes For        Votes Against       Abstentions        Broker Non-Votes
 33,669,250          339,726            131,896                 -



                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses